Research OnlyMitochondrial / longevity claims

MOTS-c

Also known as:MOTS-c peptide

Unapproved Research CompoundReference literature only. Compound is not cleared by regulatory authorities for human therapeutic administration or self-medication.

Class: Mitochondrial / longevity claims
GLP-1 relevance: Adjacent metabolic

How it works

Mitochondrial-derived peptide

Approved & studied uses

Unapproved metabolic/longevity claims

Regulatory status

Unapproved; FDA safety-risk concerns for compounding

Safety notes

FDA has identified no human exposure or safety data for the proposed routes of administration.

Sources

FDA Category 2 peptides

Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.